Belantamab mafodotin

CaLiGraph

Property	Value
rdf:type	GSK plc product owl:NamedIndividual Antibody-drug conjugate Orphan drug Therapeutic monoclonal antibody GSK plc brand Monoclonal antibody for tumors
rdfs:label	Belantamab mafodotin
owl:sameAs	dbr:Belantamab_mafodotin
prov:wasDerivedFrom	http://en.wikipedia.org/wiki/Antibody-drug_conjugate http://en.wikipedia.org/wiki/Category:Antibody-drug_conjugates http://en.wikipedia.org/wiki/Category:Orphan_drugs http://en.wikipedia.org/wiki/List_of_therapeutic_monoclonal_antibodies http://en.wikipedia.org/wiki/Multiple_myeloma http://en.wikipedia.org/wiki/Priority_review http://en.wikipedia.org/wiki/List_of_GSK_plc_products http://en.wikipedia.org/wiki/Category:GSK_plc_brands http://en.wikipedia.org/wiki/Category:Monoclonal_antibodies_for_tumors
skos:prefLabel	Belantamab mafodotin
skos:altLabel	BLENREP belantamab mafodotin
clgo:alternativeName	Blenrep
clgo:casNumber	2050232-20-5
clgo:class	Chemotherapy
clgo:drugbank	DB15719
clgo:fdaUniiCode	DB1041CXDG
clgo:kegg	D11595
clgo:chemicalFormula	C6484H10008N1728O2030S44. (C49H66N6O11)4

About: clgr:Belantamab_mafodotin